The IRE-1α-XBP-1 signaling pathway appears to be a promising target for GVHD, as inhibiting this pathway in DCs, B cells, and IECs has been shown to reduce their function and the severity of GVHD. This evidence concerns the gene ERN1 and graft versus host disease.